Log in to search using one of your social media accounts:


HRT Improves Bone Health in Young Menopausal Women HRT Improves Bone Health in Young Menopausal Women

Postmenopausal women taking hormone-replacement therapy have gains in bone-mineral density, mass, and structure, which persist for up to 2 years after treatment stops.Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Related Links:

Women who take hormone replacement therapy (HRT) to help alleviate symptoms of the menopause may have an increased risk of hearing loss, a study has found.WebMD Health News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
Authors: Tanaka S, Hishiki M, Ogasawara J, Sorimachi E, Nakayama M Abstract Although most women with type 1 diabetes experience the normal transition to menopause, there is little information about the impact of hormone replacement therapy on their glycemic profiles. A 54-year-old postmenopausal woman with fulminant type 1 diabetes was admitted to our hospital due to diabetic ketoacidosis. She was treated with fluid replacement and a continuous insulin infusion. Thereafter, her glycemic profile was well maintained by daily multiple insulin injections. However, her glycemic profiles immediately deteriorated followin...
Source: Internal Medicine - Category: Internal Medicine Tags: Intern Med Source Type: research
Conclusion This study shows a strong link between migraine and cardiovascular disease, extending the link already found between migraine and stroke. However, many questions remain. We don't know if the results are relevant to men who have migraines, as all the people in the study were women. We also don't know if the results apply to non-white populations, as most of the women in the study were white. Previous studies on stroke have shown that the group at highest risk is who get an "aura" before a migraine – sensation(s) that tells them the migraine is on its way. But this study did not ask people about ...
Source: NHS News Feed - Category: Consumer Health News Tags: Heart/lungs Neurology Source Type: news
ConclusionThis double-blind RCT found that women taking HRT less than six years after the menopause had slower artery wall thickening than those taking a placebo. This represented the main measure of atherosclerosis progression tested; other measures showed no difference, so the results were not as conclusive as they could have been. Women taking HRT 10 or more years after menopause also showed no difference in atherosclerosis progression compared with a placebo, further complicating the picture.An important limitation of this study is the lack of a patient relevant endpoint, such as cardiovascular events or mortality. Pre...
Source: NHS News Feed - Category: Consumer Health News Tags: Heart/lungs Medication Source Type: news
Abstract Post‐menopausal women with nonalcoholic steatohepatitis (NASH) are at an increased risk of hepatic fibrosis when compared with premenopausal women. Whether duration of estrogen deficiency in postmenopausal state dictates individual's fibrosis risk remains uninvestigated. We aimed to assess the associations of age at menopause and time from menopause with fibrosis severity in postmenopausal women with nonalcoholic fatty liver disease (NAFLD). Data from 488 post‐menopausal women with 1) histologic diagnosis of NAFLD and 2) self‐reported information on age at menopause were analyzed. The associations of prematu...
Source: Hepatology - Category: Internal Medicine Authors: Tags: Steatohepatitis and Metabolic Liver Disease Source Type: research
Conclusions Prolactin is not associated with a comprehensive panel of incident cardiovascular disease risk factors. Measurement of circulating prolactin levels in the community likely does not provide substantial insight into cardiometabolic risk.
Source: JAHA:Journal of the American Heart Association - Category: Cardiology Authors: Tags: Epidemiology, Obesity Source Type: research
By John Swartzberg, M.D. It's been dubbed "manopause" or "andropause" -- a midlife change for men that some claim is just like menopause for women. But there's no such thing. "Male menopause" is a creation of the pharmaceutical and supplement industries, along with unscrupulous or uninformed practitioners who feel that some of their potency -- sexual and otherwise -- is declining. It sounds perfectly reasonable at first, but scientifically speaking, there's no evidence that men go through menopause in the same way that women do. That's not to say that men's testosterone levels don't decline ...
Source: Healthy Living - The Huffington Post - Category: Consumer Health News Source Type: news
Conclusions The findings suggested that parity was an independent risk factor for the development of cataract in Chinese women.
Source: British Journal of Ophthalmology - Category: Opthalmology Authors: Tags: Lens and zonules, Epidemiology Original articles - Clinical science Source Type: research
SPECIAL FROM Next Avenue By Sheryl Kraft Everyone loses hair. In fact, it’s normal to lose between 50 and 100 hairs a day, according to the American Academy of Dermatology. But what if it seems like there’s significantly more loss than that? “Once you exceed that, you’re losing it at an abnormal rate,” says Dr. David J. Wong, clinical associate professor of dermatology at Stanford University. Contrary to popular notion, hair loss is not just a condition that men face: up to 40 percent of women in America also experience it. No ‘Bald Is Beautiful’ for Women Bruce Willis, Patric...
Source: Healthy Living - The Huffington Post - Category: Consumer Health News Source Type: news
Women who took HRT for up to 25 years no more likely to develop breast cancer, heart disease or diabetes, US scientists foundUsing hormone replacement therapy to treat uncomfortable symptoms of menopause is completely safe, according to the authors of a decade-long study.The research by New York University, presented to the American Society for Reproductive Medicine in Baltimore, suggests the risks of serious side-effects have been overstated. Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Menopause Reproduction Biology Science Cancer Heart attack Diabetes Health Society World news Source Type: news
More News: Diabetes | Endocrinology | Hormone Replacement Therapy | Hormones | Men | Menopause | Women